Filing Date | Form | Description | Issuer | View |
---|---|---|---|---|
UPLOAD |
UPLOAD |
Intellia Therapeutics, Inc. | ||
4 |
Statement of changes in beneficial ownership of securities |
Intellia Therapeutics, Inc. | ||
8-K |
Report of unscheduled material events or corporate event |
Intellia Therapeutics, Inc. | ||
POSASR |
POSASR |
Intellia Therapeutics, Inc. | ||
10-K |
Annual report which provides a comprehensive overview of the company for the past year |
Intellia Therapeutics, Inc. | ||
POS AM |
Post-effective amendment to an S-Type filing |
Intellia Therapeutics, Inc. | ||
S-8 |
Securities offered to employees pursuant to employee benefit plans |
Intellia Therapeutics, Inc. | ||
SC 13G |
A statement of beneficial ownership of common stock by certain persons |
Intellia Therapeutics, Inc. | ||
5 |
Annual filing director officer or owner of more than ten percent. |
Intellia Therapeutics, Inc. | ||
SC 13G |
A statement of beneficial ownership of common stock by certain persons |
Intellia Therapeutics, Inc. |
Displaying 351 - 360 of 564 results
Data provided by Kaleidoscope.